Proteinoid compounds, process of preparing same and uses thereof

US2023414529A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023414529-A1
Application numberUS-202318204576-A
CountryUS
Kind codeA1
Filing dateJun 1, 2023
Priority dateAug 10, 2015
Publication dateDec 28, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Proteinoid compounds characterized by a molecular weight (Mw) of at least 15,000 Da, processes of preparing such compounds and methods of use thereof, are provided. A method of monitoring the presence and metastases of cancer in a body of an individual is further disclosed.

First claim

Opening claim text (preview).

1 . A composition comprising proteinoid compounds in a form of self-assembled hollowsphere particles, wherein a hydrodynamic size of at least 80% of the self-assembled hollowsphere particles varies by less than 25% from an average hydrodynamic diameter of the entire self-assembled hollowsphere particles of the composition; wherein each of said proteinoid compounds is a random amino acid co-polymer, and wherein said proteinoid compounds are characterized by a dispersity index (1)) value of less than 1.3 and by a weight average molecular weight (Mw) of at least 15,000 Da; and wherein said random amino acid co-polymer is characterized by an IR spectrum devoid of a carbonyl stretching peak above 1700 cm −1 . 2 . The composition of claim 1 , wherein said random amino acid co-polymer consists of alpha-amino acid residues bound to each other via a primary amide bond, wherein the amino acid residue is selected from the group consisting of: val, ala, arg, asn, asp, cys, glu, gln, gly, his, met, ile, leu, lys, phe, pro, ser, thr, trp, and tyr residue. 3 . The composition of claim 1 , further comprising one or more agents selected from: labeling compound, UV blocker, an antibacterial compound, a magnetite, an antioxidant, a filler, biologically active agent, said one or more agents being attached to and/or encapsulated within said self-assembled hollowsphere. 4 . The composition of claim 1 , wherein said random amino acid co-polymer is represented by Formula 1: wherein R represents an amino acid residue selected from the group consisting of: val, ala, arg, asn, asp, cys, glu, gln, gly, his, met, ile, leu, lys, phe, pro, ser, thr, trp, and tyr residue. 5 . The composition of claim 1 , wherein the polymeric backbone is represented by the following formula: [A 1 ] x [A 2 ] y [A 3 ] z wherein: a) A 1 , is selected from Glu, Asp and Lys; b) A 2 and A 3 each independently represents an amino acid residue selected from the group consisting of: val, ala, arg, asn, asp, cys, glu, gln, gly, his, met, ile, leu, lys, phe, pro, ser, thr, trp, and tyr residue; or wherein A 2 or A 3 is absent; c) x, y, and z are integers, independently, representing the total numbers of A 1 , A 2 , and A 3 , respectively, in said polymeric backbone, such that x+y+z has a value of at least 100. 6 . The composition of claim 5 , wherein A 2 , and A 3 are each, independently selected from Asp, Arg, Tyr, His, Ala, Phe, Cys, and Ile residue. 7 . The composition of claim 5 , wherein A 1 is Glu and A 2 is selected form Asp, Phe, and Lys, and A 3 is absent. 8 . The composition of claim 5 , wherein A 1 is Glu, A 2 is Lys, and A 3 is Phe or is absent. 9 . The composition of claim 5 , wherein x, y, and z have a value such that at least one of: x/y, x/z, and y/z ranges from about 1:3 to about 3:1. 10 . The composition of claim 1 , wherein said random amino acid co-polymer is represented by the following formula [Phe] n [Arg] x [His] y [Lys] z n, x, y, and z are integers, independently, representing the total numbers of Phe, Arg, His, and Lys, respectively, in the polymeric backbone, such that n+x+y+z has a value of at least 100. 11 . The composition of claim 1 , wherein said proteinoid compounds are characterized by a dispersity index (1)) value of less than 1.1. 12 . The composition of claim 11 , wherein said proteinoid compounds are characterized by a weight average molecular weight (Mw) of at least 30,000 Da. 13 . The composition of claim 11 , wherein said proteinoid compounds are characterized by a weight average molecular weight (Mw) of between 30,000 and 300, 000 Da. 14 . A process of synthesizing the self-assembled hollowsphere particles of claim 1 , the process comprising: a) heating one or more types of amino acid to a temperature that ranges from 100° C. to 200° C. under inert gas atmosphere, thereby forming a melt; b) stirring said melt at a temperature that ranges from 100° C. to 200° C., for at least 30 min, thereby polymerizing said one or more amino acids thereby obtaining a crude mixture; c) purifying said crude mixture to obtain a solution comprising purified proteinoid compounds; and d) heating said solution to a temperature sufficient for inducing self-assembly of the purified proteinoid compounds, thereby obtaining said self-assembled hollowsphere particles; wherein said one or more types of amino acid comprise at least one of Glu, Asp and Lys. 15 . The process of claim 14 , wherein said purifying is selected from dialysis, filtration and chromatographic separation. 16 . The process of claim 14 , wherein said purified proteinoid compounds are soluble in water so as to obtain a solution. 17 . The process of claim 16 , wherein all of said purified proteinoid compounds are dissolved within said solution at a concentration of at least 1 mg/ml, and wherein a temperature of said solution ranges between 20° C. and 30° C.

Assignees

Inventors

Classifications

  • A61K9/5169Primary

    Proteins, e.g. albumin, gelatin · CPC title

  • Fluorescein, used in vivo · CPC title

  • Peptides, proteins, polyamino acids · CPC title

  • derived from hydroxy carboxylic acids · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023414529A1 cover?
Proteinoid compounds characterized by a molecular weight (Mw) of at least 15,000 Da, processes of preparing such compounds and methods of use thereof, are provided. A method of monitoring the presence and metastases of cancer in a body of an individual is further disclosed.
Who is the assignee on this patent?
Univ Bar Ilan
What technology area does this patent fall under?
Primary CPC classification A61K9/5169. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).